IDiyas

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Thomas Edward Mabry

USPTO Granted Patents = 45 

 

Average Co-Inventor Count = 7.8

ph-index = 9

Forward Citations = 281(Granted Patents)


Company Filing History:

goldMedal24 out of 4,442 
 
Eli Lilly and Company
 patents
silverMedal4 out of 202 
 
Elan Pharmaceuticals, Inc.
 patents
bronzeMedal4 out of 35 
 
Athena Neurosciences, Inc.
 patents
4. 1 out of 10 
 
Eli Lilly Company
 patents
5. 20 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2014

Loading Chart...
Loading Chart...
45 patents (USPTO):Explore Patents
1. 8778984 - Aldosterone synthase inhibitor (2014-07-15),
2. 8153807 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2012-04-10),
3. 7994176 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2011-08-09),
4. 7981918 - Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2011-07-19),
5. 7968585 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2011-06-28),
6. 7820659 - Cyclohexylimidiazole lactam derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase 1 (2010-10-26),
7. 7713979 - Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2010-05-11),
8. 7153847 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2006-12-26),
9. 6958330 - Polycyclic α-amino-ε-caprolactams and related compounds (2005-10-25),
10. 6951854 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-10-04),
11. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),
12. 6888022 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-05-03),
13. 6861558 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-03-01),
14. 6767918 - N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2004-07-27),
15. 6683075 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use (2004-01-27),

Hello! Welcome to idiyas.com, your ultimate source for all things related to innovations, inventions, inventors, patent attorneys, assignees, and patents. Let's delve into the fascinating world of inventor Thomas Edward Mabry.

Title: The Inventor Profile: Thomas Edward Mabry

Introduction:

Thomas Edward Mabry is a prolific inventor based in Indianapolis, Indiana, with an impressive portfolio of 45 patents to his name. His groundbreaking work has made significant contributions to the field of pharmaceuticals.

Latest Patents:

Mabry's recent patents showcase his innovative spirit and commitment to advancing medical science. One of his latest inventions is an aldosterone synthase inhibitor, offering a new approach to combating a range of health issues. Additionally, his work on inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 demonstrates his dedication to developing treatments for conditions such as diabetes, obesity, and hypertension.

Career Highlights:

Throughout his career, Mabry has collaborated with leading companies in the pharmaceutical industry. Notably, he has worked at Eli Lilly and Company, a renowned pharmaceutical giant known for its cutting-edge research and development activities. Mabry's expertise and creativity have undoubtedly played a crucial role in shaping the future of medicine.

Collaborations:

In his professional journey, Mabry has had the privilege of working alongside esteemed colleagues such as Jeffrey S. Nissen and Jing Wu. These collaborations have not only enriched his own work but have also paved the way for groundbreaking discoveries in the field of pharmacology.

Conclusion:

Thomas Edward Mabry's remarkable achievements as an inventor underscore his unwavering passion for innovation and his relentless pursuit of scientific excellence. His exceptional contributions to the world of pharmaceuticals continue to inspire and drive positive change in healthcare.

Thank you for exploring the inspiring story of Thomas Edward Mabry with us at idiyas.com. If you have any more questions or require further information, feel free to reach out.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…